HQL
Tekla Life Sciences Investors
18.20$
+4.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 13 | Q3 13 | Q1 14 | Q3 14 | Q1 15 | Q3 15 | Q1 16 | Q3 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q3 23 | Q4 23 | Q1 24 | Q3 24 | Q1 25 | Q3 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +132.2% | +67.5% | -11.5% | +18.5% | +71.1% | -14.3% | +0.9% | +9.6% | +56,274.8% | -99.8% | +99,900.0% | +11.8% | -0.8% | +0.0% | +0.8% | +13.0% | +0.0% | +16.6% | 0.0% | +1,617.8% | – | – | – | – | – | – | – | – | -100.0% | +2,739,279.4% | -100.0% | +199,899.1% | +1,432.4% | -93.0% | +0.0% | -7.3% | +850.5% | -36.1% | +313.2% | |
| – | – | – | – | – | – | – | – | – | – | – | -50.0% | -2.4% | +2.8% | +0.0% | -2.8% | -3.4% | +0.0% | -2.8% | +0.0% | +12.5% | – | – | – | – | – | – | – | – | – | – | – | – | -2.4% | -2.3% | +0.0% | +11.6% | -10.6% | -3.3% | +27.5% | |
| – | +132.2% | +67.5% | -11.5% | +18.5% | +71.1% | -14.3% | +0.9% | +9.6% | +56,274.8% | -1,181.2% | – | – | -243.5% | – | -237.1% | – | -201.8% | – | -168.2% | – | – | – | – | – | – | – | – | – | -100.0% | +2,405,471.3% | -100.0% | +199,899.1% | +1,298.1% | -92.3% | +0.0% | -7.3% | +718.5% | -41.4% | +389.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +117.1% | +16.8% | +7.2% | +19.5% | +10.6% | -13.4% | -9.8% | +3.7% | +58,038.6% | -99.8% | +17,302.9% | +433.8% | -88.1% | +755.0% | -87.2% | +643.8% | -87.0% | +655.2% | -86.6% | -99.6% | – | – | – | – | – | – | – | – | -7.6% | +99,900.3% | -99.9% | +199,899.9% | -31.5% | +37.8% | +0.0% | +16.8% | -13.5% | -72.8% | +341.0% | |
| – | +354.0% | -40.0% | +52.4% | +69.7% | -43.3% | +36.2% | -19.1% | -54.1% | +5,649.9% | -97.3% | +1,318.0% | +379.2% | -85.7% | +610.6% | -84.9% | +532.1% | -84.6% | +533.6% | -84.0% | -96.7% | – | – | – | – | – | – | – | – | -61.5% | +99,901.7% | -99.9% | +17,909.7% | +1,238.7% | -92.9% | +0.0% | +17.0% | +1,877.1% | -296.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -50.8% | |
| – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +352.0% | -39.5% | +51.6% | +69.3% | -155.5% | – | – | -53.3% | +77,850.0% | -99.8% | -23,737.8% | – | – | +100.0% | -140.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +199,905.6% | -133.9% | – | +0.0% | -30.3% | -234.8% | – | -50.8% | |
| – | +338.8% | -38.2% | +49.7% | +67.5% | -151.6% | – | – | -51.7% | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -99.7% | -200.0% | – | -101.3% | – | – | – | – | |
| – | +352.0% | -39.5% | +51.6% | +69.3% | -155.5% | – | – | -53.3% | +77,850.0% | -99.8% | -23,737.8% | – | – | +100.0% | -140.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +199,905.6% | -133.9% | – | +0.0% | -30.3% | -234.8% | – | -50.8% | |
| – | +338.8% | -38.2% | +49.7% | +67.5% | -151.6% | – | – | -51.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +194,494.2% | -133.9% | – | -0.6% | -65.1% | -234.8% | – | -50.8% |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.